Patisiran
Transthyretin (TTR)-Mediated Amyloidosis
Alnylam PharmaceuticalsPhase 1
—
Rating in progress
Patisiran in Transthyretin (TTR)-Mediated Amyloidosis is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Dormant